Chemistry
Chelating Agent
92%
Radium
45%
Macrocyclic Ligand
45%
Chelation
34%
Liquid-Liquid Interface
31%
Macrocycle
30%
Complexation
27%
Chemistry
27%
DOTA
26%
stability
23%
Coordination Chemistry
21%
Metal Ion
21%
Solvation
20%
Rare Earth Element
20%
Lanthanoid Atom
20%
Radioisotope
19%
Sum-Frequency Generation
18%
Solvent Extraction
18%
Phosphoric Acid
17%
18-Crown-6
17%
Donor
16%
Radiochemical Yield
13%
Mass Spectrometry
13%
Amino Acid
13%
Density Functional Theory
13%
Ambient Reaction Temperature
12%
Actinium
10%
Inorganic Chemistry
10%
Polyamide
10%
Coordination Compound
10%
Alkaline Earth Metal
10%
Alanine
10%
Guanidine
10%
Methylglyoxal
10%
Carbon Dioxide
10%
formation
8%
Interfacial Structure
7%
Nuclear Property
6%
Sodium Citrate
6%
Thin Layer Chromatography
6%
Mobile Phase Composition
6%
Ethylenediaminetetraacetic Acid
6%
NMR Spectroscopy
6%
Enzymatic Hydrolysis
6%
Oligomer
6%
Sarcosine
5%
Barium
5%
Magnetic Property
5%
Chemical Phenomena
5%
Transition Metal
5%
Pharmacology, Toxicology and Pharmaceutical Science
Chelating Agent
100%
Actinium 225
56%
Radioisotope
43%
Lanthanide
31%
Macrocyclic Compound
29%
Barium Ion
22%
Neoplasm
22%
Tetraxetan
22%
Metal Ion
21%
Prostate Specific Membrane Antigen
17%
Complexation
15%
Pentetic Acid
13%
Malignant Neoplasm
10%
Hydrolase
10%
Alkaline Earth Metal
10%
2,5-Dimethoxy-4-iodoamphetamine
10%
Bismuth 213
10%
Coordination Compound
10%
Polyamide
10%
Lanthanum
10%
Alanine
10%
Receptor
10%
Neuroendocrine Tumor
10%
Oligomer
10%
Diseases
8%
Biodistribution
7%
Prostate Cancer
6%
Therapeutic Effect
5%
Ethylenediaminetetraacetic Acid
5%
Picolinic Acid
5%
Medicine and Dentistry
Actinium 225
46%
Chelating Agent
24%
Lanthanum
20%
Nuclear Medicine
20%
Radioisotope
18%
Neoplasm
17%
Prostate Specific Membrane Antigen
14%
Targeted Therapy
13%
Xenograft
11%
Single Drug Dose
10%
Auger Electron Spectroscopy
10%
Density Functional Theory
10%
Radionuclide Therapy
10%
Peptide Receptor
10%
Neuroendocrine Tumor
10%
Macrocyclic Compound
8%
Lanthanide
6%
Calorimetry
6%
Tumor Xenograft
6%
X Ray Diffraction
5%
Therapy Effect
5%